SHANDONG TOPSCIENCE BIOTECH CO., LTD.

Established in 2005, SHANDONG TOPSCIENCE BIOTECH CO., LTD. is one of the few Chinese manufacturers of sodium hyaluronate to hold GMP certification with 'A' API registration status, producing injection-grade, eye-drop-grade, and excipient-grade sodium hyaluronate across a wide range of molecular weights with ultra-low impurity, endotoxin, heavy-metal, and microbial contamination levels. The company holds a European CEP certificate (since 2015), PMDA (Japan) GMP approval (2018), Shandong FDA GMP certification (2019), a Korean KDMF, and a CDSCO Form 41 registration in India, and in 2023 launched China's first sterile sodium hyaluronate, followed in 2025 by the country's first medical-device-grade chondroitin sulfate sodium. Manufacturing and exporting active pharmaceutical ingredients, intermediates and fine chemicals, bio products, natural extracts, pharmaceutical excipients, and medical aesthetic skincare ingredients, the company offers CMO contract manufacturing and serves markets across North America, Latin America, Europe, Australasia, the Middle East, Africa, and Asia.